Indrayani Biotech Market Cap ($8.36M USD)
Indrayani Biotech Market Cap ($8.36M USD). As of Oct. 6, 2026, Indrayani Biotech (INDRANIB) market capitalisation is ₹75.20 Cr ($8.36M), with 7.34 Cr shares outstanding at a current price of ₹10.24 on BSE, ranking 3378 out of 5368 companies by market cap in our screener. Indrayani Biotech operates in the FMCG sector and is classified as a Small Cap stock. Examine INDRANIB earnings report for recent quarterly revenue, profit and EPS trends.
Market Cap History of Indrayani Biotech (Last 10 Years)
INDRANIB market capitalisation from year-end BSE closing prices over the last 10 years. Compare with INDRANIB DCF valuation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Indrayani Biotech
INDRANIB year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. For live price, earnings and the complete company profile, see INDRANIB share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹75.20 Cr
$8.36M USD
|
₹10.24 | BSE | -9.46% |
| 2025 |
₹83.06 Cr
$9.23M USD
|
₹11.31 | BSE | -68.79% |
| 2024 |
₹266.14 Cr
$29.57M USD
|
₹36.24 | BSE | -42.63% |
| 2023 |
₹463.90 Cr
$51.54M USD
|
₹63.17 | BSE | -16.83% |
| 2022 |
₹557.76 Cr
$61.97M USD
|
₹75.95 | BSE | +183.93% |
| 2021 |
₹196.45 Cr
$21.83M USD
|
₹26.75 | BSE | +249.67% |
| 2020 |
₹56.18 Cr
$6.24M USD
|
₹7.65 | BSE | +16.44% |
| 2019 |
₹48.25 Cr
$5.36M USD
|
₹6.57 | BSE | -17.88% |
| 2018 |
₹58.75 Cr
$6.53M USD
|
₹8.00 | BSE | +128.57% |
| 2017 |
₹25.70 Cr
$2.86M USD
|
₹3.50 | BSE | -57.16% |
| 2016 |
₹60.00 Cr
$6.67M USD
|
₹8.17 | BSE | -15.69% |
| 2015 |
₹71.16 Cr
$7.91M USD
|
₹9.69 | BSE | +99.38% |
| 2010 |
₹35.69 Cr
$3.97M USD
|
₹4.86 | BSE | +57.79% |
| 2009 |
₹22.62 Cr
$2.51M USD
|
₹3.08 | BSE | +50.98% |
| 2008 |
₹14.98 Cr
$1.66M USD
|
₹2.04 | BSE | - |